Background and objective: Obesity has been associated with increased androgenicity in women. There are, however, major inconsistencies in available data concerning the possible association between androgenicity and leptin in humans.The objectives of this study were to evaluate the impact of body mass index on androgens and the potential contribution of leptin in determination of androgen levels in women. Methods: The study included 80 healthy females with an established Body Mass Index (BMI). They were divided into 4 groups. First group, 30 normal weight subjects (BMI<25 Kg/m 2 ), second group, 25 overweight subjects (BMI=25-29.9 Kg/m 2 ) , third group,15 obese grade-I subjects (BMI=30-34.9 Kg/m 2 ) and forth group, 10 obese grade-II subjects (BMI>35 Kg/m 2 ). Serum, leptin, free testosterone, androstenedione, glucose, lipid profile and body mass index were measured. Results: There was no statistically significant difference in median serum androstenedione, while free testosterone was significantly lower (14.5 pg/ml) in obese grade II and higher in normal weight (60 pg/ml) and statistically significant increase in serum leptin with increase in body mass index. Serum free testosterone was lower (23.5 pg/ml) in subjects with highest quartile serum leptin and higher (43pg/ml), in subjects with lowest quartile serum leptin, the difference was not significant statistically.
Introduction
Interestingly, serum androgens are positively associated with body mass index (BMI) not only in polycystic ovary syndrome (PCOS) ,but also in women with simple obesity 1 . This, together with a fall in luteinizing hormone levels with increasing BMI 2, 3 , suggests that androgen synthesis may take place not only in adrenals and ovaries but also in adipose tissue. Some research focused on sex steroid conversion in human adipose tissue, specifically investigating the expression and activity of 17-hydroxysteroid dehydrogenases (17-HSDs), which represent a major switch regulating sex steroid activation and inactivation at the pre-receptor level [4] [5] [6] .
The major androgens are testosterone, androstenedione, and dehydroepiandrosterone (DHEA). Half of the circulating testosterone is produced peripherally from androstenedione and other androgen precursors. In premenopausal women, testosterone is produced in the ovaries and adrenals, while in postmenopausal women, testosterone is produced by the adrenals and the peripheral conversion of androstenedione in adipose tissue 7 . Leptin, the hormone encoded by the obesity gene, is secreted mainly from adipocytes . 8 It regulates energy balance by reducing food intake and increasing energy expenditure 9 . A main function may be to initiate protective neuroendocrine responses during starvation 10 . As leptin levels rise due to obesity and other factors 11 , the physiological regulation including androgens 12, 13 present in non-obese subjects may be altered. Some studies suggest that both hyperleptinemia 14, 15 and relative alterations in androgen levels, ie hypoandrogenicity in men and hyperandrogenicity in women, may be associated with increased risk for cardiovascular diseases 16 . Since testosterone is involved in the regulation of fat mass, it may be speculated that the relation between testosterone and leptin is indirect. However, experimental data support the idea that testosterone acts directly on the adipocyte as expression and secretion of leptin is reduced in cultured adipocytes after coincubation with testosterone or dihydrotestosterone, suggesting a direct effect as well 17 . Our hypothesis was to examine the effect of BMI on circulating androgens (free testosterone, androstenedione) and influence of leptin on androgens in women reproductive age. The difference in median of selected serum hormones between study groups categorized by body mass index . Table 1 : The difference in mean age between study groups categorized by body mass index .
Results
A total of 80 reproductive age women were enrolled in the study with an established BMI. They were divided into 4 groups. As shown in Table 1 , there was no statistical significant difference in mean age between the study groups, their ages ranged from 18 to 38 years with mean ±SD (28.8±6.1) years. Descriptive statistics for serum study hormones concentrations are presented in Table 2 which shows there that was no statistically significant difference in median serum androstenedione, between the study subjects. The median of serum free testosterone was significantly lower (14.5 pg/ml) in morbid obese and significantly higher in normal weight (60 pg/ ml) with p=0.001, with presence of statistically significant difference between study groups. While a statistically significant elevation was found in a median of serum leptin with increase in body mass index between the study groups with p<0.001. A hightly significant negative weak correlation was found between BMI and serum free testosterone in present study (r= -0.374 p=0.001) as shown in figure 3 .
As shown in Table 3 , no important or statistically significant differences between study groups for serum glucose and lipid profile.
To study the net and independent effect of BMI on serum free testosterone after controlling for the possible confounding effect of age, serum total cholesterol, serum TG and fasting glucose, a multiple linear regression model was used. (mg/dl) increase in serum fasting glucose the serum free testosterone is expected to increase by an average of 0.43 pg/ml after controlling for the remaining independent variables included in the model, Table 4 . To study the net and independent effect of BMI serum Androstenedione after controlling for the possible confounding effect of age, serum total cholesterol, serum TG and fasting glucose a multiple linear regression model was used. The model was not significant statistically and none of the included explanatory variables showed an important or statistically significant association with the outcome variable, Table 5 . The objective of the study was to identify the relationship between well-defined measures of body adiposity via body mass index and circulating androgens, leptin concentrations in healthy reproductive age women. Reproductive age women with higher levels of adiposity have higher concentrations of serum leptin (Table 2 , Figure 1 ) this finding agreed with several previous reports which showed positive correlations between adiposity and leptin concentrations 19-22. Higher body mass index was associated with higher serum leptin concentrations. Current study findings support the view that increased adiposity measured as BMI, percent body fat( central and peripheral fat) are all associated with increased leptin exposure in non-smoking women. Since increased BMI 23 and central fat 24, 25 are associated with increased risk for breast cancer in prospective studies, increased leptin exposure associated with obesity and central adiposity could explain the greater incidence of breast cancer in overweight or obese postmenopausal women. This idea is also supported by the findings from several experimental studies in which leptin stimulated breast carcinogenesis 26, 27 . However, very few epidemiologic studies have assessed leptin concentrations in relation to breast cancer risk. Two small case-control studies, one in postmenopausal 28 and the other in premenopausal 29 women, and a single prospective study 30 found no association between leptin and breast cancer. Thus, we recommend that more epidemiological studies are clearly needed to confirm the leptin-breast cancer association in reproductive age women. Many previous studies did not find an association of obesity with Table 6 : Association between serum leptin and each of androstenedione and free testosterone.
Discussion
Serum leptin-categories levels of androstenedione 18, [31] [32] [33] in either pre-or post-menopausal women. Our data are consistent with these observations. Most of studies in pre-menopausal women have shown an increase in free testosterone with increasing body Weight 31, 34, 35 . our results are inconsistent to these observations, but in agreement with other studies which confirm an inverse correlations in women between androgen and BMI, wist to hip ratio, although their statistic significance is less evident 16, 36, 37 , however there are conflicting data on this subject. The matter of female obesity and androgens may still need in-depth research. It has been proposed that the relationship between BMI and androgens is mediated by obesityrelated changes in insulin and bio available of insulin like growth factor I (IGF-I). In vitro studies have shown that both insulin and insulin like growth factor I ( IGF-I ) can stimulate ovarian androgen synthesis 38, 39 . However, this gonadotropic effect of insulin and IGF-I may be of less significance before menopause mainly in reproductive age when circulating sex-steroid hormones are under the tight control of luteinizing hormone (LH) and follicle stimulating hormone (FSH) and regulated by powerful feed-back mechanisms this hypothesis is more pronounced to explain present result inconsistency with some others 31, 34, 35 and the choice of our subjects was women in reproductive age while the other studies focused primarily on postmenopausal women or a combination of pre and postmenopausal participants. Moreover, the effect of BMI may be less evident against the background of high testosterone hormone concentration after the cessation of ovulatory activity. In subjects investigated in the present study, the relationship between leptin and BMI was positive linear, as can be seen in Figure1. The findings showed the same results as previously reported studies in obese women 21, 40 . There is a growing bulk of evidence suggesting that testosterone may infuence leptin levels. Testosterone administration reduces leptin levels in Hypogonadal 41, 42 and eugonadal men 43 in adolescents with delayed puberty 44 , and in female to male transsexuals 45 . Since testosterone is involved in the regulation of fat mass, it may be speculated that the relation between testosterone and leptin is indirect. However, experimental data support the idea that testosterone acts directly on the adipocyte as expression and secretion of leptin is reduced in cultured adipocytes after coincubation with testosterone or dihydrotestosterone 12, 17 , suggesting a direct effect as well, these observations may give an explanation for current finding which shows an inverse association between testosterone and leptin. We observed a significant association between serum androstenedione and serum leptin, androstenedione found to be higher in inter-quartile range of serum leptin this from one hand while from another hand serum free testosterone was lowest in subjects with highest quartile serum leptin, Table 6 this different behavioral of both androgens towered leptin hormone suggesting a complex relationships between these hormones.
The results of present study provide evidence that an increase in BMI influences the circulating levels of free testosterone hormone negatively, in the presence of the powerful feed-back mechanisms that control the synthesis of androgens and estrogens in reproductive age. A clear inverse association between circulating leptin and free testosterone was observed. Finally, recommend that the identification of potentially modifiable life-style or investigate study hormonal determinants is important because of the increasing epidemiological evidence linking these hormones to cancer risk. 
